Is someone you love at risk?

Similar documents
patient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer

Understanding Hereditary Breast and Ovarian Cancer. Maritime Hereditary Cancer Service

BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide

Familial Breast Cancer Referrals and Risk Management

BRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet

What are breast cancer clinical trials?

Prevention GENEration. The Importance of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOC)

In recent years the number of DNA genetic tests that you can

1in3 WHAT WE DO. Our vision is to bring forward the day when all cancers are cured.

BRCA1 and BRCA2 for men

Breast cancer and genetics

The recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).

BRCA1 & BRCA2 GeneHealth UK

Lesson Plan: Genetic Testing and Hereditary Cancer

Are you worried about prostate cancer? 1

Patient Support Guide

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases

Office of Population Health Genomics

Breast Cancer s Link to Ovarian Cancer: It s in Your Genes. foundationforwomenscancer.org

Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010

What s In Your Genes: How changes in the BRCA1/BRCA2 genes

Information for patients and the public and patient information about DNA / Biobanking across Europe

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service

if your family has a history

Understanding Your Risk of Ovarian Cancer

75 YEARS OF WORKING TO BUILD A HEALTHY AUSTRALIA NHMRC

What is DCIS? Contents. The breasts

Understanding genetic tests for men who have a family history of breast and ovarian cancer. Information and decision aid

TARGET YOUR FUTURE RADIATION ONCOLOGY

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

A guide to prostate cancer clinical trials

If you were diagnosed with cancer today, what would your chances of survival be?

PROVIDER POLICIES & PROCEDURES

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer

The Center for Cancer Care. Comprehensive and compassionate care

VOLLEY FOR THE CURE 15

Breast Cancer Screening

A survey conducted by Ovarian Cancer Australia: A report summarising findings on a family history and genetic testing survey

Hereditary Breast and Ovarian Cancer (HBOC)

Over the years, Baker IDI researchers have been responsible for many ground-breaking advances including:

Reduce Your Risk of Breast Cancer

Information sheet for an application for an additional location Medicare provider/registration number

TAKING PART IN CANCER TREATMENT RESEARCH STUDIES

BREAST CANCER PATHOLOGY

An Introduction to PROSTATE CANCER

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

European Parliament resolution on breast cancer in the European Union (2002/2279(INI))

Cancer: Genetic testing can save lives

U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet

ScreenWise. Breast, Cervical, and Hereditary Cancer Screenings OCTOBER 28, 2015

Expansion of the Ontario Breast Screening Program (OBSP) to Include Women Aged 30 to 69 at High Risk for Breast Cancer

Cancer Services for Adults and Children

Make a Difference: Oncology Nursing

Breast cancer in families. This booklet explains what a family history of breast cancer is, and what this may mean for you or your family.

Understanding genetic tests for breast and ovarian cancer that runs in the family Information and decision aid

What Cancer Patients Need To Know

Guidance Document Enhancing cancer genomics practice through education, surveillance and policy Introductions

Easy Read. How can we make sure everyone gets the right health care? How can we make NHS care better?

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine

Setting the Stage for Cancer Advocacy in Africa: What, Why & How? Financial Disclosure 11/15/2011. Acknowledgement NONE. Funding Support provided by:

Tell a Friend, Save a Life: The Breast Cancer Prevention & Detection Kit

co-sponsored by the Health & Physical Education Department, the Health Services Office, and the Student Development Center

Treatment of colon cancer

Breakthrough Treatment Options for Breast Cancer

Efficacy of two models of delivering information about treatment-focused genetic testing among young women newly diagnosed with breast cancer

Genomic medicine in Australia. Professor Warwick Anderson Chief Executive Officer National Health and Medical Research Council

Prostate Cancer Risk Epidemiology and Genetics. Robert F. Marschke, Jr., M.D. November 2, 2013

Breast Screening Explained. We can supply this information in other languages, in large print, on audio or in Braille.

Genetic Testing in Research & Healthcare

Major change for BERT and BEWT Funds!

Breast cancer in the family

Understanding genetic tests for Lynch syndrome. Information and decision aid

This vision does not represent government policy but provides useful insight into how breast cancer services might develop over the next 5 years

A guide for the patient

The State of Federal Appropriations for Cancer Prevention and Research. ACS CAN Leadership Summit & Lobby Day September 21, 2009

Religious and Spiritual Issues in African Americans at Increased Risk for Cancer

Research Strategy

Phyllodes tumours: borderline malignant and malignant

PROSTATE CANCER. Straight Talk for African-American Men and Their Families

About breast cancer i

Lung Cancer. Know how to stay strong

Advocacy Activities Calendar

Video.

Cancer Genetic Counseling

PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE

Breast Health Program

Impact of Breast Cancer Genetic Testing on Insurance Issues

Using Agile IT to Improve Multi- Disciplinary Team Coordination

Ovarian. Leading the Charge against. Cancer

Early detection of breast cancer

KEEPING ABREAST OF FUTURE NEED:

Balanced. translocations. rarechromo.org. Support and Information

CHR Lunch n Learn Series

Understanding Clinical Trials and Research

Commonwealth of Australia 2008

NEW HYBRID IMAGING TECHNOLOGY MAY HAVE BIG POTENTIAL FOR IMPROVING DIAGNOSIS OF PROSTATE CANCER

Ductal carcinoma in situ (DCIS)

GENETIC COUNSELING IS IT A CAREER FOR YOU? Judith L Miller, MS, LGC April 8, 2014

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD

Go Red for Women: Fundraising Guide

Transcription:

Is someone you love at risk? About 10,000 Australian families carry a breast cancer genetic fault They have an increased risk of developing breast cancer. To find out more about these mutations we collect biological samples and genetic, medical and social information from families with strong histories of breast cancer. This information is used to study familial breast cancer - how to prevent it and smarter and faster ways to detect and treat it more effectively. We have only ONE aim... to prevent breast cancer in women and men with a high genetic risk.

What the experts say about kconfab: kconfab, based in Australia, represents one of the most rigorously established and managed facilities world wide...it is a world class research resource in the area of human genetics of breast cancer Independent international NH&MRC reviewer 2005 Australian scientists and clinicians working with kconfab have one of the world s best breast cancer research resources. I would like to see the international effort modelled along similar lines to those used by kconfab, which maps the genetic make up of all cancers. It would be a 20-year leap forward in the fight against cancer. Bruce Stillman, PhD, FRS, Cold Spring Harbor Laboratory, New York

One in eleven Australian women will be diagnosed with breast cancer But the risk is not spread evenly - those women with a family history are at higher risk. Those at highest risk belong to families who have mutations in the breast cancer genes, the best known being BRCA1 and BRCA2. The mutations are passed from one generation to the next. Everyone who inherits a mutation is at increased risk of developing cancer: breast and ovarian cancer in women, breast and prostate cancer in men yes, men also develop breast cancer in high risk families. All too often these genetic cancers arise early in life, often during childbearing years and the middle of a career. We can help. People with strong family histories of breast and ovarian cancer can now be offered genetic testing to discover whether they carry a mutation in one of the known breast cancer genes. Frequent clinical surveillance to detect breast cancer at its earliest stage, when the chance of a cure is greater, is also available.

Who we are and where we work kconfab brings together more than 100 researchers, cancer geneticists, clinicians, surgeons, genetic counsellors, psychosocial researchers, oncologists, pathologists and epidemiologists - from all over Australia and New Zealand. Cancer specialists and researchers are based at 42 public hospitals and medical research institutions in all States and Territories in Australia and New Zealand. Outreach clinics are also serviced in remote areas of New South Wales, Queensland, Western Australia and Canberra.

kconfab is virtually unique in terms of the quality with which families have been characterised and data collected Independent international NHMRC reviewer 2005 We collect family histories, biological samples and comprehensive life style and clinical data from high risk Australian families. We are regarded as one of the best publiclyavailable resources for familial breast cancer in the world. We are the major driver of breast cancer research in Australia and provide lifestyle data and biological samples to more than 50 research projects here and overseas.

We MUST do more research. We MUST reach more families. We MUST... Identify ALL the genes responsible for familial breast cancer. Discover the best ways to detect tumours at the earliest stages. Pinpoint the genetic and lifestyle factors that may help protect against the disease. We need hundreds, perhaps thousands, of families to generate enough statistical evidence to provide the best possible advice, surveillance and treatment.

There is a clear need for a facility of this kind given the common occurrence of breast cancer and the impact of familial cancer on affected women (and men) Independent international NHMRC reviewer 2005 To find these answers we will: Continue to enrol hundreds of high risk families. Remain in close contact with these families for many more years at least until 2030. Because the risk of cancer is passed from generation to generation, our work is long term. Keep pace with advancing technology, taking advantage of the technical advances flowing from mapping the human genome. RESEARCH NEEDS TIME and MONEY We need $10 million over the next 5 years

kconfab Family How is kconfab supported? Since its inception in 1997, we have been supported entirely by competitive grants from National and State funding bodies. We will continue to seek this funding but Government agencies cannot continue indefinitely kconfab needs new sources to secure enduring funding. We need to be able to double our annual budget. YOU know someone with breast cancer... how can YOU help? Huge improvements in technology during the past decade have provided the power to solve genetic problems that were previously beyond reach. We need funds to bring these technologies on stream and use them to solve problems evident in our families.

You can help by: Donation Support of our fundraising activities As an ambassador Whether an individual or a corporation you can support this world class research with a donation to the National Breast Cancer Foundation for kconfab. Remember, however you make your donation ensure you mark it for kconfab research. Contact the Friends of kconfab to arrange a meeting with one of our leading researchers. Phone kconfab on 03 9656 1542 or our toll free number 1800 221 894 or NBCF on 02 9299 4090. Visit www.nbcf.org.au and use the online donation facility. Send your cheque made out to National Breast Cancer Foundation to GPO Box 4126 Sydney 2001 Donate using your credit card by calling the NBCF on 02 9299 4090 For further information about kconfab visit the home site at www.kconfab.org

We need your help Because we are a national consortium, funds donated to Friends of kconfab need to be managed by a national group such as the National Breast Cancer Foundation (NBCF). NBCF is Australia s leading not-for-profit organisation established to promote and support research of breast cancer. It has awarded more than $20 million for new research since its formation in 1994. NBCF will provide a legal entity for all funds raised to be held ready for distribution to kconfab. How will you know about our progress We will keep you informed in a number of ways: Friends of kconfab newsletter Annual Report Meet and greet opportunities to hear first hand from our researchers Website updates

Why kconfab? Dr Kathleen Cuningham was a pioneer of breast cancer treatment in Australia. Her career as a surgeon spanned 43 years. Born on 2nd November 1898, she gained the Degree of Master of Surgery at the University of Sydney in 1939. The Kathleen Cuningham Foundation (KCF), a breast cancer research support organization, was formed in 1994. The KCF provided the funding to start our research study, which we named kconfab - the Kathleen Cuningham Consortium for research on Familial breast cancer in her honour. kconfab contact details: kconfab Manager, Heather Thorne Research Department Peter MacCallum Cancer Centre East Melbourne, 3002 Phone: 03 9656 1542 email: heather.thorne@petermac.org www.kconfab.org Printed on enviromentally accreditated 100% recycled paper, using environmentally friendly soy based inks.